Anthracycline treatment and resistance in four human cancer cell lines
收藏官方服务：
资源简介：
Anthracycline treatment and resistance in four human cancer cell lines
应用场景：
创建时间：
2010-04-14
相关数据集
RNF25-Mediated NF-κB Activation Drives Anti-Apoptosis and Therapy Resistance in Cancer
RNF25-Mediated NF-κB Activation Drives Anti-Apoptosis and Therapy Resistance in Cancer
integrated proteome resources90
Table1_Exploring a four-gene risk model based on doxorubicin resistance-associated lncRNAs in hepatocellular carcinoma.DOCX
Background: Liver cancer is a lethal cancer type among which hepatocellular carcinoma (HCC) is the most common manifestation globally. Drug resistance is a central problem impeding the efficiency of H
NIAID Data Ecosystem40
High-throughput transcriptome profiling of non-small cell lung cancer cell lines sensitive or resistant to CPL304110 FGFR inhibitor. High-throughput transcriptome profiling of non-small cell lung cancer cell lines sensitive or resistant to CPL304110 FGFR inhibitor
FGFR signalling is one of the most prominent pathways involved in cell growth and development, as well as cancer progression. FGFR1 amplification occurs in approximately 20% of all squamous cell lung
NIAID Data Ecosystem30
Cytotoxicity of Ruthenium–Arene Complexes Containing β‑Ketoamine Ligands
New ruthenium(II) arene derivatives (arene = p-cymene, benzene, hexamethylbenzene) containing β-ketoamine ligands L′ (HL′ in general; in detail, HLph,ph = (4Z)-3-methyl-4-((phenylamino)(phenyl)meth
NIAID Data Ecosystem50
A Hotspot Phosphorylation Site on SHP2 Drives Oncoprotein Activation and Drug Resistance
This study identifies phosphorylation of SHP2 at tyrosine 62 (pY62) as a conserved mechanism of resistance to allosteric SHP2 inhibitors. By stabilizing an open, active SHP2 conformation, pY62 phenoco
DataCite Commons2026-04-10 更新30
